Literature DB >> 22232177

Expression, purification, crystallization and preliminary X-ray crystallographic analysis of human β-galactosidase.

Kimihito Usui1, Umeharu Ohto, Toshinari Ochi, Toshiyuki Shimizu, Yoshinori Satow.   

Abstract

β-D-Galactosidase (β-Gal) is an exoglycosidase that cleaves β-galactosides from glycoproteins, sphingolipids and keratan sulfate. This study reports the expression, purification, crystallization and preliminary X-ray crystallographic analysis of human lysosomal β-Gal. The sitting-drop vapour-diffusion method was used to crystallize β-Gal in complexes with its product galactose and with the inhibitor 1-deoxygalactonojirimycin. The resulting crystals were isomorphous and belonged to space group P2(1). The crystals of the β-Gal-galactose and the β-Gal-inhibitor complexes had unit-cell parameters a = 94.8, b = 116.1, c = 140.3 Å, β = 92.2° and a = 94.8, b = 116.0, c = 140.3 Å, β = 92.2°, respectively. Diffraction data were collected to 1.8 Å resolution for both crystals.
© 2012 International Union of Crystallography. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22232177      PMCID: PMC3253840          DOI: 10.1107/S1744309111047920

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  19 in total

1.  A classification of glycosyl hydrolases based on amino acid sequence similarities.

Authors:  B Henrissat
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

2.  Detecting and overcoming crystal twinning.

Authors:  T O Yeates
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

3.  Processing of lysosomal beta-galactosidase. The C-terminal precursor fragment is an essential domain of the mature enzyme.

Authors:  A van der Spoel; E Bonten; A d'Azzo
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

4.  Human small intestine -galactosidases: specific assay of three different enzymes.

Authors:  N G Asp; A Dahlqvist
Journal:  Anal Biochem       Date:  1972-06       Impact factor: 3.365

5.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

6.  Separation and isolation of rat and human intestinal beta-galactosidases.

Authors:  D H Alpers
Journal:  J Biol Chem       Date:  1969-03-10       Impact factor: 5.157

Review 7.  Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.

Authors:  J W Callahan
Journal:  Biochim Biophys Acta       Date:  1999-10-08

8.  Beta-galactosidase deficiency: an approach to chaperone therapy.

Authors:  Yoshiyuki Suzuki
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

9.  Identification of Glu-268 as the catalytic nucleophile of human lysosomal beta-galactosidase precursor by mass spectrometry.

Authors:  J D McCarter; D L Burgoyne; S Miao; S Zhang; J W Callahan; S G Withers
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  2 in total

1.  Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.

Authors:  Umeharu Ohto; Kimihito Usui; Toshinari Ochi; Kenjiro Yuki; Yoshinori Satow; Toshiyuki Shimizu
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

2.  Structural basis of pharmacological chaperoning for human β-galactosidase.

Authors:  Hironori Suzuki; Umeharu Ohto; Katsumi Higaki; Teresa Mena-Barragán; Matilde Aguilar-Moncayo; Carmen Ortiz Mellet; Eiji Nanba; Jose M Garcia Fernandez; Yoshiyuki Suzuki; Toshiyuki Shimizu
Journal:  J Biol Chem       Date:  2014-04-15       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.